Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myriad Genetics Inc (MYGN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Myriad Genetics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 899923.
Total stock buying since 2005: $951,678.
Total stock sales since 2005: $299,133,778.
Total stock option exercises since 2005: $124,356,444.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 339,094 | $8,717,764 | 0 | $0 |
| 2023 | 0 | $0 | 75,671 | $1,405,272 | 0 | $0 |
| 2022 | 0 | $0 | 26,424 | $426,674 | 0 | $0 |
| 2021 | 0 | $0 | 782,929 | $25,835,272 | 748,188 | $18,223,254 |
| 2020 | 15,000 | $249,330 | 14,431 | $342,733 | 0 | $0 |
| 2019 | 12,860 | $314,218 | 235,687 | $10,177,500 | 198,307 | $5,080,990 |
| 2018 | 0 | $0 | 695,789 | $27,855,954 | 685,805 | $18,069,907 |
| 2017 | 6,000 | $111,922 | 46,531 | $1,454,851 | 30,000 | $493,800 |
| 2016 | 11,000 | $233,889 | 78,637 | $2,347,407 | 80,619 | $1,219,367 |
| 2015 | 0 | $0 | 370,999 | $15,320,891 | 378,317 | $7,948,988 |
| 2014 | 0 | $0 | 1,448,950 | $53,054,636 | 1,451,407 | $26,892,939 |
| 2013 | 0 | $0 | 320,505 | $10,320,336 | 320,505 | $4,027,236 |
| 2012 | 0 | $0 | 1,249,711 | $34,019,684 | 1,259,196 | $11,387,218 |
| 2011 | 0 | $0 | 213,614 | $5,120,688 | 214,422 | $2,716,958 |
| 2010 | 0 | $0 | 205,976 | $4,710,100 | 169,866 | $1,462,794 |
| 2009 | 1,300 | $42,319 | 570,759 | $25,284,784 | 564,063 | $7,308,282 |
| 2008 | 0 | $0 | 398,433 | $23,861,221 | 505,598 | $6,771,508 |
| 2007 | 0 | $0 | 881,185 | $40,235,657 | 770,771 | $9,640,404 |
| 2006 | 0 | $0 | 324,336 | $8,593,443 | 286,134 | $3,112,799 |
| 2005 | 0 | $0 | 2,448 | $48,911 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-10 | 0 | $0 | 15,000 | $343,950 | 0 | $0 |
| 2024-09 | 0 | $0 | 71,012 | $1,957,171 | 0 | $0 |
| 2024-08 | 0 | $0 | 19,038 | $531,062 | 0 | $0 |
| 2024-05 | 0 | $0 | 234,044 | $5,885,581 | 0 | $0 |
| 2023-12 | 0 | $0 | 30,000 | $572,850 | 0 | $0 |
| 2023-11 | 0 | $0 | 30,000 | $470,610 | 0 | $0 |
| 2023-06 | 0 | $0 | 8,638 | $198,760 | 0 | $0 |
| 2023-03 | 0 | $0 | 6,433 | $151,046 | 0 | $0 |
| 2023-01 | 0 | $0 | 600 | $12,006 | 0 | $0 |
| 2022-12 | 0 | $0 | 20,000 | $303,000 | 0 | $0 |
| 2022-06 | 0 | $0 | 6,424 | $123,674 | 0 | $0 |
| 2021-10 | 0 | $0 | 1,420 | $44,835 | 0 | $0 |
| 2021-09 | 0 | $0 | 77,758 | $2,616,038 | 77,000 | $2,039,729 |
| 2021-08 | 0 | $0 | 302,034 | $10,600,042 | 298,225 | $7,714,250 |
| 2021-07 | 0 | $0 | 175,603 | $5,801,556 | 175,603 | $4,534,722 |
| 2021-06 | 0 | $0 | 3,139 | $95,796 | 0 | $0 |
| 2021-05 | 0 | $0 | 26,502 | $825,983 | 19,360 | $376,939 |
| 2021-04 | 0 | $0 | 46,649 | $1,438,382 | 40,000 | $778,800 |
| 2021-03 | 0 | $0 | 58,000 | $1,740,000 | 58,000 | $1,338,814 |
| 2021-02 | 0 | $0 | 80,000 | $2,377,040 | 80,000 | $1,440,000 |
| 2021-01 | 0 | $0 | 11,824 | $295,600 | 0 | $0 |
| 2020-11 | 15,000 | $249,330 | 0 | $0 | 0 | $0 |
| 2020-09 | 0 | $0 | 2,804 | $38,630 | 0 | $0 |
| 2020-02 | 0 | $0 | 11,627 | $304,103 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-11 | Diaz Paul J (President and CEO) | Sale | 15,000 | 22.93 | 343,950 |
| 2024-09-11 | Diaz Paul J (President and CEO) | Sale | 15,000 | 26.72 | 400,800 |
| 2024-09-09 | Dreismann Heinrich (Director) | Sale | 10,000 | 27.05 | 270,520 |
| 2024-09-03 | Reitan Colleen F (Director) | Sale | 46,012 | 27.95 | 1,285,851 |
| 2024-08-21 | Ancona Margaret (SVP, Chief of Staff) | Sale | 11,538 | 27.82 | 320,987 |
| 2024-08-19 | Kumar Rashmi (Director) | Sale | 7,500 | 28.01 | 210,075 |
| 2024-05-15 | Diaz Paul J (President and CEO) | Sale | 75,000 | 25.07 | 1,880,400 |
| 2024-05-14 | Diaz Paul J (President and CEO) | Sale | 95,000 | 25.21 | 2,394,760 |
| 2024-05-13 | Newcomer Lee Nisley (Director) | Sale | 6,200 | 25.30 | 156,860 |
| 2024-05-13 | Diaz Paul J (President and CEO) | Sale | 57,844 | 25.13 | 1,453,561 |
| 2023-12-01 | Riggsbee Richard Bryan (Chief Financial Officer) | Sale | 30,000 | 19.09 | 572,850 |
| 2023-11-01 | Riggsbee Richard Bryan (Chief Financial Officer) | Sale | 30,000 | 15.69 | 470,610 |
| 2023-06-02 | Spiegelman Daniel K (Director) | Sale | 8,638 | 23.01 | 198,760 |
| 2023-03-27 | Lambert Nicole (Chief Operating Officer) | Sale | 6,433 | 23.48 | 151,046 |
| 2023-01-18 | Riggsbee Richard Bryan (Chief Financial Officer) | Sale | 600 | 20.01 | 12,006 |
| 2022-12-27 | Riggsbee Richard Bryan (Chief Financial Officer) | Sale | 20,000 | 15.15 | 303,000 |
| 2022-06-06 | Spiegelman Daniel K (Director) | Sale | 6,424 | 19.25 | 123,674 |
| 2021-10-01 | Lambert Nicole (See Remarks) | Sale | 1,420 | 31.57 | 44,835 |
| 2021-09-27 | Lambert Nicole (See Remarks) | Sale | 10,112 | 33.10 | 334,747 |
| 2021-09-23 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 200 | 35.06 | 7,012 |
| 2021-09-17 | Hart Jayne B. (Chief People Officer) | Sale | 67,446 | 33.72 | 2,274,279 |
| 2021-09-17 | Hart Jayne B. (Chief People Officer) | Option Ex | 77,000 | 26.49 | 2,039,729 |
| 2021-08-27 | Lambert Nicole (See Remarks) | Sale | 945 | 34.50 | 32,602 |
| 2021-08-24 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 30,000 | 35.57 | 1,067,100 |
| 2021-08-24 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 30,000 | 27.07 | 812,100 |
| 2021-08-23 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 50,000 | 35.32 | 1,766,000 |
| 2021-08-23 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 50,000 | 27.07 | 1,353,500 |
| 2021-08-05 | Phanstiel S. Louise (Director) | Sale | 47,881 | 35.04 | 1,677,750 |
| 2021-08-05 | Phanstiel S. Louise (Director) | Option Ex | 60,000 | 23.34 | 1,400,400 |
| 2021-08-05 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 28,225 | 35.57 | 1,004,019 |
| 2021-08-05 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 28,225 | 27.07 | 764,050 |
| 2021-08-04 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 50,000 | 35.41 | 1,770,349 |
| 2021-08-04 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 50,000 | 27.07 | 1,353,500 |
| 2021-08-03 | Riggsbee Richard Bryan (Chief Financial Officer) | Sale | 14,983 | 35.14 | 526,472 |
| 2021-08-03 | Langer Dennis (Director) | Sale | 30,000 | 34.75 | 1,042,500 |
| 2021-08-03 | Langer Dennis (Director) | Option Ex | 30,000 | 25.39 | 761,700 |
| 2021-08-03 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 50,000 | 34.27 | 1,713,250 |
| 2021-08-03 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 50,000 | 25.38 | 1,269,000 |
| 2021-07-13 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 43,295 | 33.72 | 1,459,777 |
| 2021-07-13 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 43,295 | 26.49 | 1,146,884 |
| 2021-07-12 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 50,000 | 33.55 | 1,677,550 |
| 2021-07-12 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 50,000 | 26.49 | 1,324,500 |
| 2021-07-09 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 50,000 | 32.52 | 1,625,850 |
| 2021-07-09 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 50,000 | 24.15 | 1,207,500 |
| 2021-07-07 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 32,308 | 32.14 | 1,038,379 |
| 2021-07-07 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 32,308 | 26.49 | 855,838 |
| 2021-06-17 | Spiegelman Daniel K (Director) | Sale | 3,139 | 30.52 | 95,796 |
| 2021-05-28 | Spiegelman Daniel K (Director) | Sale | 7,142 | 28.99 | 207,025 |
| 2021-05-04 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 19,360 | 31.97 | 618,958 |
| 2021-05-04 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 19,360 | 19.47 | 376,939 |
| 2021-04-27 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 40,000 | 31.47 | 1,258,800 |
| 2021-04-27 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 40,000 | 19.47 | 778,800 |
| 2021-04-19 | Lambert Nicole (See Remarks) | Sale | 6,649 | 27.01 | 179,582 |
| 2021-03-29 | Hart Jayne B. (Chief People Officer) | Sale | 58,000 | 30.00 | 1,740,000 |
| 2021-03-29 | Hart Jayne B. (Chief People Officer) | Option Ex | 58,000 | 23.08 | 1,338,814 |
| 2021-02-16 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 80,000 | 29.71 | 2,377,040 |
| 2021-02-16 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 80,000 | 18.00 | 1,440,000 |
| 2021-01-08 | Parkinson Paul (EVP Strategy and Innovation) | Sale | 11,824 | 25.00 | 295,600 |
| 2020-11-11 | Phanstiel S. Louise (Director) | Buy | 15,000 | 16.62 | 249,330 |
| 2020-09-15 | Ford Alexander (Chief Operating Officer) | Sale | 2,804 | 13.78 | 38,630 |
| 2020-02-12 | Lambert Nicole (President, MGL) | Sale | 4,354 | 19.73 | 85,913 |
| 2020-02-05 | Ford Alexander (President, MWH) | Sale | 7,273 | 30.00 | 218,190 |
| 2019-12-26 | Ford Alexander (President, MWH) | Option Ex | 1,307 | 15.98 | 20,885 |
| 2019-12-13 | Gilbert Walter Phd (Director) | Buy | 5,860 | 25.60 | 149,998 |
| 2019-11-07 | Henderson John T (Director) | Buy | 7,000 | 23.46 | 164,220 |
| 2019-08-01 | Tobin Bernard (President Crescendo BioScience) | Sale | 11,712 | 40.00 | 468,480 |
| 2019-08-01 | Riggsbee Richard Bryan (Chief Financial Officer) | Sale | 25,000 | 41.50 | 1,037,575 |
| 2019-08-01 | King Gary A. (Exec. VP International Ops) | Sale | 60,000 | 43.04 | 2,582,220 |
| 2019-08-01 | King Gary A. (Exec. VP International Ops) | Option Ex | 60,000 | 23.31 | 1,398,780 |
| 2019-08-01 | Capone Mark Christopher (President & C.E.O.) | Sale | 137,000 | 44.00 | 6,028,000 |
| 2019-08-01 | Capone Mark Christopher (President & C.E.O.) | Option Ex | 137,000 | 26.73 | 3,661,325 |
| 2019-03-12 | Mcdade Ralph L (President Myriad RBM, Inc.) | Sale | 1,975 | 31.00 | 61,225 |
| 2018-07-11 | Capone Mark Christopher (President & C.E.O.) | Sale | 80,000 | 41.00 | 3,280,000 |
| 2018-07-11 | Capone Mark Christopher (President & C.E.O.) | Option Ex | 80,000 | 30.12 | 2,409,600 |
| 2018-07-11 | Henderson John T (Director) | Sale | 30,000 | 42.06 | 1,261,800 |
| 2018-07-11 | Henderson John T (Director) | Option Ex | 30,000 | 24.39 | 731,700 |
| 2018-07-11 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 50,000 | 43.34 | 2,167,050 |
| 2018-07-11 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 50,000 | 30.34 | 1,517,000 |
| 2018-07-11 | Marsh Richard M (E.V.P., General Counsel) | Sale | 70,672 | 43.01 | 3,039,461 |
| 2018-07-11 | Marsh Richard M (E.V.P., General Counsel) | Option Ex | 70,672 | 23.11 | 1,633,229 |
| 2018-06-18 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 60,000 | 40.12 | 2,407,200 |
| 2018-06-18 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 60,000 | 30.12 | 1,807,200 |
| 2018-06-18 | Marsh Richard M (E.V.P., General Counsel) | Sale | 33,000 | 40.00 | 1,320,000 |
| 2018-06-18 | Marsh Richard M (E.V.P., General Counsel) | Option Ex | 33,000 | 30.34 | 1,001,220 |
| 2018-06-08 | Langer Dennis (Director) | Sale | 13,664 | 39.35 | 537,678 |
| 2018-06-08 | Langer Dennis (Director) | Option Ex | 13,664 | 21.29 | 290,906 |
| 2018-06-07 | Langer Dennis (Director) | Sale | 3,096 | 39.35 | 121,827 |
| 2018-06-07 | Langer Dennis (Director) | Option Ex | 3,096 | 21.29 | 65,913 |
| 2018-06-06 | Langer Dennis (Director) | Sale | 3,609 | 39.37 | 142,089 |
| 2018-06-06 | Langer Dennis (Director) | Option Ex | 3,609 | 21.29 | 76,835 |
| 2018-06-06 | Gilbert Walter Phd (Director) | Sale | 1,189 | 39.80 | 47,322 |
| 2018-06-06 | Gilbert Walter Phd (Director) | Option Ex | 1,189 | 24.39 | 28,999 |
| 2018-06-05 | Langer Dennis (Director) | Sale | 1,227 | 39.90 | 48,957 |
| 2018-06-05 | Langer Dennis (Director) | Option Ex | 1,227 | 21.29 | 26,122 |
| 2018-06-05 | Gilbert Walter Phd (Director) | Sale | 28,811 | 39.68 | 1,143,278 |
| 2018-06-05 | Gilbert Walter Phd (Director) | Option Ex | 28,811 | 24.39 | 702,700 |
| 2018-06-04 | Langer Dennis (Director) | Sale | 18,404 | 39.90 | 734,319 |
| 2018-06-04 | Langer Dennis (Director) | Option Ex | 18,404 | 22.84 | 420,347 |
| 2018-06-01 | Langer Dennis (Director) | Sale | 30,000 | 38.90 | 1,167,000 |
| 2018-06-01 | Langer Dennis (Director) | Option Ex | 30,000 | 24.40 | 732,000 |
| 2018-05-30 | Capone Mark Christopher (President & C.E.O.) | Sale | 90,000 | 38.00 | 3,420,000 |
| 2018-05-30 | Capone Mark Christopher (President & C.E.O.) | Option Ex | 90,000 | 22.93 | 2,063,700 |
| 2018-05-30 | Langer Dennis (Director) | Sale | 10,000 | 37.92 | 379,250 |
| 2018-05-30 | Langer Dennis (Director) | Option Ex | 10,000 | 24.39 | 243,900 |
| 2018-05-30 | Marsh Richard M (E.V.P., General Counsel) | Sale | 33,139 | 38.00 | 1,259,282 |
| 2018-05-30 | Marsh Richard M (E.V.P., General Counsel) | Option Ex | 33,139 | 30.34 | 1,005,437 |
| 2018-05-21 | Langer Dennis (Director) | Sale | 10,000 | 35.90 | 359,000 |
| 2018-05-21 | Langer Dennis (Director) | Option Ex | 10,000 | 24.39 | 243,900 |
| 2018-01-22 | King Gary A. (Exec. VP International Ops) | Sale | 34,445 | 39.40 | 1,357,133 |
| 2018-01-22 | King Gary A. (Exec. VP International Ops) | Option Ex | 34,445 | 18.73 | 645,327 |
| 2018-01-22 | Marsh Richard M (E.V.P., General Counsel) | Sale | 37,654 | 40.25 | 1,515,611 |
| 2018-01-22 | Marsh Richard M (E.V.P., General Counsel) | Option Ex | 41,429 | 28.30 | 1,172,647 |
| 2018-01-18 | King Gary A. (Exec. VP International Ops) | Sale | 3,120 | 38.12 | 118,934 |
| 2018-01-18 | King Gary A. (Exec. VP International Ops) | Option Ex | 3,120 | 14.88 | 46,425 |
| 2018-01-18 | Marsh Richard M (E.V.P., General Counsel) | Sale | 40,000 | 38.25 | 1,530,000 |
| 2018-01-18 | Marsh Richard M (E.V.P., General Counsel) | Option Ex | 40,000 | 30.12 | 1,204,800 |
| 2018-01-12 | Marsh Richard M (E.V.P., General Counsel) | Sale | 13,759 | 36.25 | 498,763 |
| 2017-12-14 | Gilbert Walter Phd (Director) | Sale | 7,500 | 33.19 | 248,924 |
| 2017-12-11 | Dreismann Heinrich (Director) | Sale | 6,000 | 33.50 | 201,000 |
| 2017-11-13 | Ford Alexander (President, MGL) | Sale | 3,031 | 31.64 | 95,897 |
| 2017-09-01 | Henderson John T (Director) | Sale | 30,000 | 30.30 | 909,030 |
| 2017-09-01 | Henderson John T (Director) | Option Ex | 30,000 | 16.46 | 493,800 |
| 2017-02-23 | Henderson John T (Director) | Buy | 4,000 | 18.58 | 74,308 |
| 2017-02-22 | Henderson John T (Director) | Buy | 2,000 | 18.81 | 37,614 |
| 2016-09-12 | Henderson John T (Director) | Sale | 2,007 | 20.21 | 40,567 |
| 2016-09-12 | Henderson John T (Director) | Option Ex | 2,007 | 10.60 | 21,274 |
| 2016-09-09 | Henderson John T (Director) | Sale | 27,993 | 20.51 | 574,248 |
| 2016-09-09 | Henderson John T (Director) | Option Ex | 27,993 | 10.60 | 296,725 |
| 2016-08-19 | Capone Mark Christopher (President & C.E.O.) | Buy | 10,000 | 21.24 | 212,399 |
| 2016-08-12 | Mcdade Ralph L (President Myriad RBM, Inc.) | Buy | 1,000 | 21.49 | 21,490 |
| 2016-06-21 | Ford Alexander (President, MGL) | Sale | 18,637 | 30.87 | 575,342 |
| 2016-06-21 | Ford Alexander (President, MGL) | Option Ex | 16,449 | 18.73 | 308,172 |
| 2016-06-16 | Marsh Richard M (E.V.P., General Counsel) | Option Ex | 4,170 | 23.98 | 99,996 |
| 2016-04-06 | King Gary A. (Exec. VP International Ops) | Sale | 15,000 | 39.03 | 585,450 |
| 2016-04-06 | King Gary A. (Exec. VP International Ops) | Option Ex | 15,000 | 18.00 | 270,000 |
| 2016-04-01 | King Gary A. (Exec. VP International Ops) | Sale | 15,000 | 38.12 | 571,800 |
| 2016-04-01 | King Gary A. (Exec. VP International Ops) | Option Ex | 15,000 | 14.88 | 223,200 |
| 2015-12-11 | Gilbert Walter Phd (Director) | Sale | 5,000 | 42.23 | 211,149 |
| 2015-12-08 | Phanstiel S. Louise (Director) | Sale | 5,000 | 44.00 | 220,000 |
| 2015-11-05 | Dreismann Heinrich (Director) | Sale | 60,000 | 44.44 | 2,666,100 |
| 2015-11-05 | Dreismann Heinrich (Director) | Option Ex | 60,000 | 26.50 | 1,590,000 |
| 2015-11-04 | Marsh Richard M (E.V.P., General Counsel) | Sale | 35,000 | 44.50 | 1,557,500 |
| 2015-11-04 | Marsh Richard M (E.V.P., General Counsel) | Option Ex | 35,000 | 22.93 | 802,550 |
| 2015-10-28 | King Gary A. (Exec. VP International Ops) | Sale | 10,000 | 42.82 | 428,200 |
| 2015-10-28 | King Gary A. (Exec. VP International Ops) | Option Ex | 10,000 | 23.98 | 239,800 |
| 2015-10-28 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 50,962 | 41.86 | 2,133,269 |
| 2015-10-28 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 50,962 | 22.93 | 1,168,558 |
| 2015-10-27 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 12,336 | 41.80 | 515,644 |
| 2015-10-27 | Lanchbury Jerry S (Chief Scientific Officer) | Option Ex | 12,336 | 19.73 | 243,389 |
| 2015-10-26 | Lanchbury Jerry S (Chief Scientific Officer) | Sale | 11,491 | 41.80 | 480,323 |
Insider trading activities including stock purchases, stock sales, and option exercises of MYGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Myriad Genetics Inc (symbol MYGN, CIK number 899923) see the Securities and Exchange Commission (SEC) website.